Israel Lowy
0000-0002-5421-2485
3 papers found
Refreshing results…
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
Tolerability and antitumor activity of cemiplimab, a human monoclonal anti–PD-1, as monotherapy in patients with pretreated non-small cell lung cancer (NSCLC): Data from the Phase 1 NSCLC expansion cohort
Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses
Missing publications? Search for publications with a matching author name.